PROCEPT BioRobotics Corporation Common Stock (NASDAQ: PRCT) last traded at $21.68, up 4.58% on the session. The quote above updates while this page is open; the figures below are drawn from PROCEPT BioRobotics Corporation Common Stock’s own filings and are restated only when a new one is published.
PROCEPT BioRobotics Corporation Common Stock trades on NASDAQ under the ticker PRCT. Its market capitalisation is $1.24 billion.
Valuation measures for PROCEPT BioRobotics Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.24B |
|---|---|
| Enterprise value | $1.15B |
| Price / sales | 3.68 |
| Price / book | 3.65 |
| Beta | 0.84 |
Trailing-twelve-month figures tagged in PROCEPT BioRobotics Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $337.34M |
|---|---|
| Net income (TTM) | -$109.76M |
| EPS (TTM) | -$1.95 |
| Gross margin | 64.22% |
| Operating margin | -33.86% |
| Return on equity | -32.27% |
| Cash | $227.91M |
Range and volume for PRCT over the past 52 weeks.
| 52-week high | $42.43 |
|---|---|
| 52-week low | $16.67 |
| Volume | 821.1K |
| Average volume | 1.61M |
| Previous close | $20.73 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.